Viewing Study NCT03223961


Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2026-02-25 @ 6:32 PM
Study NCT ID: NCT03223961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2017-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None myelodysplastic syndrome View
None erythropoetin View